Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Eukaryotic Gene Expression
Impact-faktor: 2.156 5-jähriger Impact-Faktor: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2020033468
pages 125-136

MTHFR-C677T Gene Polymorphism and Susceptibility to Acute Lymphoblastic Leukemia in Children: A Meta-Analysis

Yu Li
Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
Yu-Xin Pei
Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
Li-Na Wang
Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
Cong Liang
Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
Yan-Lai Tang
Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
Xiao-Li Zhang
Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
Li-Bin Huang
Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
Xue-Qun Luo
Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
Zhi-Yong Ke
Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China

ABSTRAKT

Background: The association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) and childhood acute lymphoblastic leukemia (ALL) is inconsistent.
Objective: To explore the relationship between MTHFR-C677T polymorphism and susceptibility to childhood ALL.
Methods: PubMed, EMBASE, Web of Science, CNKI, Wanfang, VIP, and other databases were searched from the establishment of the database to November 2019, and all the case-control studies that met the inclusion criteria were collected. Stata 15.0 was used for meta-analysis, with calculation of the odds ratio (OR) of the relationship between MTHFR-C677T polymorphism and childhood ALL susceptibility. Ethnicity was analyzed by subgroup analysis.
Results: A total of 26 studies were included in this meta-analysis, including 4,682 children with ALL and 7144 controls. The results showed that there was no significant difference in the comparison of population of allele model, dominant gene model, recessive gene model, homozygous gene model, heterozygous gene model, and the comparison of Caucasian children. The results of the Asian child analysis suggested that the combined OR of the dominant gene model (CC + CT versus TT), homozygous model (CC versus TT) and heterozygous model (CT versus TT) was 1.32 (95% confidence interval [CI]: 1.03-1.70), 1.37 (95% CI: 1.02-1.84), and 1.27 (95% CI: 1.01-1.59), respectively, with statistically significant differences. However, there was no significant difference between the allele model and recessive gene model among Asian children.
Conclusion: The MTHFR C677T polymorphism is related to ALL in children, especially in Asian children. CC + CT, CC, and CT genotypes can increase the risk of ALL, but no association has been found in Caucasian children.

REFERENZEN

  1. National Institute of Cancer. ChildhoodAcute Lymphoblastic Leukemia Treatment (PDQ): Patient Version 2002. Available from: https://www.cancer.gov/types/leukemia/ patient/child-all-treatment-pdq.

  2. Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7:e577.

  3. Howlader N, Noone A, Yu M, Cronin KA. Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer. Am J Epidemiol. 2012;176: 347-56.

  4. Shah A, Coleman MP. Increasing incidence of childhood leukaemia: a controversy re-examined. Br J Cancer. 2007;97:1009-12.

  5. Li X, Liao Q, Zhang S, Chen M. Association of methylenetetrahytrofolate reductase (MTHFR) C677T and A1298C polymorphisms with the susceptibility of child-hood acute lymphoblastic leukaemia (ALL) in Chinese population. Eur J Med Res. 2014;19:5.

  6. Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical significance of minimal residual disease in leukemia. Int J Oncol. 2000;17:1277-87.

  7. Hesari A, Maleksabet A, Tirkani AN, Ghazizadeh H, Iranifar E, Mohagheg F, Anoshrvani AA, Ghasemi F. Evaluation of the two polymorphisms rs1801133 in MTHFR and rs10811661 in CDKN2A/B in breast cancer. J Cell Biochem. 2019;120(2):2090-7.

  8. Gong JM, Shen Y, Shan WW, He YX. The association between MTHFR polymorphism and cervical cancer. Sci Rep. 2018;8:7244.

  9. Ferlazzo N, Curro M, Zinellu A, Caccamo D, Isola G, Ventura V, Carru C, Matarese G, Ientile R. Influence of MTHFR genetic background on p16 and MGMT methylation in oral squamous cell cancer. Int J Mol Sci. 2017;18:E724.

  10. Mahmoud LB, Mdhaffar M, Frikha R, Ghozzi H, Hakim A, Sahnoun Z, Elloumi M, Zeghal K. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia. Adv Clin Exp Med. 2018;27:1061-8.

  11. Chatzidakis K, Goulas A, Athanassiadou-Piperopoulou F, Fidani L, Koliouskas D, Mirtsou V. Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in greek patients. Pediatr Blood Cancer. 2006;47:147-51.

  12. Reddy H, Jamil K. Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population. Leuk Lymphoma. 2006;47:1333-9.

  13. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-5.

  14. Schnakenberg E, Mehles A, Cario G, Rehe K, Seidemann K, Schlegelberger B, Elsner HA, Welte KH, Schrappe M, Stanulla M. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet. 2005;6:23.

  15. Zou R, He X, Wu Y, Tian X, You Y, Zheng M, Li W, Zou H, Liu H, Zhu X, Zhu C. TS gene polymorphisms correlate with susceptibility to acute lymphocytic leukemia in children. Med Sci Monit. 2017;23:3095-104.

  16. Tong N, Fang Y, Li J, Wang M, Lu Q, Wang S, Tian Y, Rong L, Sun J, Xu J, Zhang Z. Methylenetetrahydrofolate reductase polymorphisms, serum methylenetetrahydrofolate reductase levels, and risk of childhood acute lympho-blastic leukemia in a Chinese population. Cancer Sci. 2010;101:782-6.

  17. Yeoh AE, Lu Y, Chan JY, Chan YH, Ariffin H, Kham SK, Quah TC. Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res. 2010;34:276-83.

  18. Chan JY, Ugrasena DG, Lum DW, Lu Y, Yeoh AE. Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol. 2011;29:116-23.

  19. Karathanasis NV, Stiakaki E, Goulielmos GN, Kalmanti M. The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia. Genet Test Mol Biomarkers. 2011;15:5-10.

  20. Nikbakht M, MalekZadeh K, Kumar JA, Askari M, Marwaha RK, Kaul D, Kaur J. Polymorphisms of MTHFR and MTR genes are not related to susceptibility to childhood ALL in North India. Exp Oncol. 2012;34:43-8.

  21. Kreile M, Rots D, Piekuse L, Cebura E, Grutupa M, Kovalova Z, Lace B. Lack of association between poly-morphisms in genes MTHFR and MDR1 with risk of childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev. 2014;15:9707-11.

  22. Sazawal S, Chaubey R, Kaur P, Chikkara S, Kumar B, Bakshi S, Arya LS, Raina V, Das Gupta A, Saxena R. MTHFR gene polymorphisms and the risk of acute lymphoblastic leukemia in adults and children: a case control study in India. Indian J Hematol Blood Transfus. 2014;30:219-25.

  23. Gutierrez-Alvarez O, Lares-Asseff I, Galaviz-Hernandez C, Reyes-Espinoza EA, Almanza-Reyes H, Sosa-Macias M, Chairez Hernandez I, Salas-Pacheco JM, Bailon-Soto CE. Involvement of MTHFR and TPMT genes in susceptibility to childhood acute lymphoblastic leukemia (ALL) in Mexicans. Drug Metab Pers Ther. 2016;31:41-6.

  24. Pei JS, Hsu CM, Tsai CW, Chang WS, Ji HX, Hsiao CL, Miao CE, Hsu YN, Bau DT. The association of methylenetetrahydrofolate reductase genotypes with the risk of childhood leukemia in Taiwan. PLoS One. 2015;10:e0119776.

  25. Kaluzna EM, Strauss E, Swiqtek-Koscielna B, Zajqc-Spychala O, Gowin E, Nowak JS, Rembowska J, Januszkiewicz-Lewandowska D. The methylenetetrahydrofolate reductase 677T-1298C haplotype is a risk factor for acute lymphoblastic leukemia in children. Medicine (Baltimore). 2017;96:e9290.

  26. Gomez-Gomez Y, Organista-Nava J, Villanueva-Flores F, Estrada-Brito JS, Rivera-Ramnez AB, Saavedra-Herrera MV, Jimenez-Lopez MA, Illades-Aguiar B, Leyva-Vazquez MA. Association between the 5,10-MTHFR 677C > T and RFC1 80G > a polymorphisms and acute lymphoblastic leukemia in Mexican population. Arch Med Res. 2019;50(4):175-80.

  27. Amigou A, Rudant J, Orsi L, Goujon-Bellec S, Leverger G, Baruchel A, Bertrand Y, Nelken B, Plat G, Michel G, Haouy S, Chastagner P, Ducassou S, Rialland X, Hemon D, Clavel J. Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE). Cancer Causes Control. 2012;23:1265-77.

  28. Azhar MR, Rahimi Z, Vaisi-Raygani A, Akramipour R, Madam H, Rahimi Z, Parsian A. Lack of association between MTHFR C677T and A1298C polymorphisms and risk of childhood acute lymphoblastic leukemia in the Kurdish population from Western Iran. Genet Test Mol Biomarkers. 2012;16:198-202.

  29. de Jonge R, Tissing WJ, Hooijberg JH, Jansen G, Kaspers GJ, Lindemans J, Pieters GJ, Pieters R. Polymorphisms in folate-related genes and risk of pediatric acute lympho-blastic leukemia. Blood. 2009;113:2284-9.

  30. Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A, Sinnett D. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood. 2004;103:252-7.

  31. Mosaad YM, Abousamra NK, Elashery R, Fawzy IM, Eldein OA, Sherief DM, El Azab HM. Methylenetetrahy-drofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children. Leuk Lymphoma. 2015;56: 2699-705.

  32. Oliveira E, Alves S, Quental S, Ferreira F, Norton L, Costa V, Amorim A, Prata MJ. The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J Pediatr Hematol Oncol. 2005;27:425-9.

  33. Sood S, Das R, Trehan A, Ahluwalia J, Sachdeva MU, Varma N, Bansal D, Marwaha RK. Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute lymphoblastic leukemia in north Indians. Leuk Lymphoma. 2010;51:928-32.

  34. Damnjanovic T, Milicevic R, Novkovic T, Jovicic O, Bunjevacki V, Jekic B, Lukovic L, Novakovic I, Redzic D, Milasin J. Association between the methylenetetrahydro-folate reductase polymorphisms and risk of acute lympho-blastic leukemia in Serbian children. J Pediatr Hematol Oncol. 2010;32:e148-50.

  35. Thirumaran RK, Gast A, Flohr T, Burwinkel B, Bartram C, Hemminki K, Kumar R. MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood. 2005;106:2590-1; author reply 2591-2.

  36. Xia X, Duan Y, Cui J, Jiang J, Lin L, Peng X, Wang Y, Guo B, Liu S, Lei X. Association of methylenetetrahydrofolate reductase gene-gene interaction and haplotype with susceptibility to acute lymphoblastic leukemia in Chinese children. Leuk Lymphoma. 2017;58:1887-92.

  37. Oosterom N, de Jonge R, Smith D, Pieters R, Tissing WJE, Fiocco M, van Zelst BD, van den Heuvel-Eibrink MM, Heil SG. Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia. PLoS One. 2019;14:e0221591.

  38. Yousef AM, Farhad R, Alshamaseen D, Alsheikh A, Zawiah M, Kadi T. Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2019;83:755-62.

  39. Umerez M, Gutierrez-Camino A, Munoz-Maldonado C, Martin-Guerrero I, Garcia-Orad A. MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy. Pharmgenomics Pers Med. 2017;10:69-78.

  40. Jilma B, Kamath S, Lip GY. ABC of antithrombotic therapy: antithrombotic therapy in special circumstances. II-In children, thrombophilia, and miscellaneous conditions. BMJ. 2003;326:93-6.

  41. Ferrari A, Torrezan GT, Carraro DM, Aguiar Junior S. Association of folate and vitamins involved in the 1-carbon cycle with polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and global DNA methylation in patients with colorectal cancer. Nutrients. 2019;11:1368.

  42. Li SY, Ye JY, Liang EY, Zhou LX, Yang M. Association between MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: a meta-analysis based on 51 case-control studies. Med Sci Monit. 2015;21:740-8.

  43. Lin S, Lin Q, Zeng X. The association between methy-lenetetrahydrofolate reductase C677 > T polymorphisms and risk of pediatric acute lymphoblastic leukemia in Asia. J Cancer Res Ther. 2014;10 Suppl:C210-4.


Articles with similar content:

CTLA-4 SNPs (CT60A/G, -1722T/C, -1661G/A, and -318C/T) and Systemic Lupus Erythematosus: A Meta-Analysis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.24, 2014, issue 2
Xuebing Feng, Yun Zhu, Jing Wang
Association between HIF1α 1772 C/T Polymorphism and Breast Cancer Susceptibility: A Systematic Review
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 4
Ting Wang
ABCB1 Polymorphisms and Childhood Acute Lymphoblastic Leukemia Risk: A Meta-Analysis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 2
Lu Zhan, Junlan Lian, Zhengyang Shao, Sunyao Wang, Haili Jin, Jiajun Ding
Association between Methionine Synthase Reductase A66G Polymorphism and Male Infertility: A Meta-Analysis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 1
Fan Jin, Xiangli Wu, Lin Zhang, Weihai Xu
Association of ERCC1 and ERCC2 Gene Polymorphisms with Pancreatic Cancer Risk: A Meta-Analysis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.30, 2020, issue 3
Fuyi Xie, Yinyu Mu, Qi Sun, En Zhang